Publication | Open Access
Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy
15
Citations
27
References
2015
Year
Use of IMP was the most cost-effective strategy, supporting its routine clinical use.
| Year | Citations | |
|---|---|---|
Page 1
Page 1